Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FBYVH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,147
Award facts
- Contract value 100% obligated
- $12,146.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. on August 27, 2025, for the supply of Jakafi 5 mg tablets (60-count packaging). This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a specific pharmaceutical fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete directly in the federal pharmaceutical procurement marketplace. The product will be delivered to Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its primary operations.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, holds a significant $499.999 billion IDC with the Defense Logistics Agency under the SPE2DB program, valid through November 2026. This contract vehicle enables DLA to issue firm fixed-price delivery orders for a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities worldwide. The company has demonstrated consistent success in securing federal pharmaceutical contracts and serves as a critical supplier within the Department of Defense healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FBYVH?
SPE2DB25FBYVH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FBYVH worth?
The government has obligated $12,147 on SPE2DB25FBYVH.
Is contract SPE2DB25FBYVH an order under another contract?
Yes. SPE2DB25FBYVH is a delivery order under SPE2DB24D9105, an indefinite delivery contract.
Was contract SPE2DB25FBYVH competed?
The extent of competition for SPE2DB25FBYVH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award